← Leaderboards
Qingshan Li
Captozyme, Inc.
$2,517,068
Attributed
$2,517,068
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $704.9K · FY2010–15$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,517,068 · 4
By mechanism
R44$2,266,296 · 2
R43$250,772 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Effective Therapy”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$467,028,615
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$263,149,639
- Constance Ann Benson · University Of California, San Diego$228,304,380
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
Effective TherapyCalcium OxalateOxalate DecarboxylaseSourceUrinaryAbsorptionOral AdministrationOxalatesPrincipal InvestigatorInterceptHealthcareBacillus SubtilisEnzymesBacteriaConfidential InformationPrimary HyperoxaluriaOxalobacter FormigenesHyperoxaluriaIntestinesExcretory FunctionFunctional DisorderGastrointestinal Tract StructureFermentationFibrosis
Grant awards (6)
Oxalate Reduction by Oral Administration of Oxalate Degrading Enzymes$560,860
R44 · FY2015 · DK · contact PI
Oxalate Reduction by Oral Administration of Oxalate Degrading Enzymes$447,264
R44 · FY2014 · DK · contact PI
Reduction of Dietary Oxalate$704,911
R44 · FY2013 · AT · contact PI
Reduction of Dietary Oxalate$553,261
R44 · FY2012 · AT · contact PI
Oxalate Reduction by Oral Administration of Oxalate Degrading Enzymes$150,788
R43 · FY2010 · DK · contact PI
Reduction of Dietary Oxalate$99,984
R43 · FY2010 · AT · contact PI